Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids.
Rogmans C, Dittrich J, Hamm E, Weimer JP, Holthaus D, Arnold N, Flörkemeier I, Maass N, Jansen P, Dempfle A, Bauerschlag DO, Hedemann N. Rogmans C, et al. Among authors: maass n. Sci Rep. 2024 Nov 6;14(1):26926. doi: 10.1038/s41598-024-78442-y. Sci Rep. 2024. PMID: 39506058 Free PMC article.
ADAM17 inhibition enhances platinum efficiency in ovarian cancer.
Hedemann N, Rogmans C, Sebens S, Wesch D, Reichert M, Schmidt-Arras D, Oberg HH, Pecks U, van Mackelenbergh M, Weimer J, Arnold N, Maass N, Bauerschlag DO. Hedemann N, et al. Among authors: maass n. Oncotarget. 2018 Mar 23;9(22):16043-16058. doi: 10.18632/oncotarget.24682. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662625 Free PMC article.
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids.
Hedemann N, Herz A, Schiepanski JH, Dittrich J, Sebens S, Dempfle A, Feuerborn J, Rogmans C, Tribian N, Flörkemeier I, Weimer J, Krüger S, Maass N, Bauerschlag DO. Hedemann N, et al. Among authors: maass n. Cancers (Basel). 2021 Apr 23;13(9):2039. doi: 10.3390/cancers13092039. Cancers (Basel). 2021. PMID: 33922533 Free PMC article.
ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer.
Rogmans C, Kuhlmann JD, Hugendieck G, Link T, Arnold N, Weimer JP, Flörkemeier I, Rambow AC, Lieb W, Maass N, Bauerschlag DO, Hedemann N. Rogmans C, et al. Among authors: maass n. Cancers (Basel). 2021 Nov 6;13(21):5563. doi: 10.3390/cancers13215563. Cancers (Basel). 2021. PMID: 34771725 Free PMC article.
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
Mundhenke C, Weigel MT, Sturner KH, Roesel F, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Hilpert F, Jonat W, Maass N. Mundhenke C, et al. Among authors: maass n. J Cancer Res Clin Oncol. 2008 Dec;134(12):1397-405. doi: 10.1007/s00432-008-0408-0. Epub 2008 May 9. J Cancer Res Clin Oncol. 2008. PMID: 18465140
Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.
Bräutigam K, Bauerschlag DO, Weigel MT, Biernath-Wüpping J, Bauknecht T, Arnold N, Maass N, Meinhold-Heerlein I. Bräutigam K, et al. Among authors: maass n. Transl Oncol. 2009 Aug 18;2(3):164-73. doi: 10.1593/tlo.09121. Transl Oncol. 2009. PMID: 19701501 Free PMC article.
259 results